Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
Pancreas. 2021;50(5):679-684. doi: 10.1097/MPA.0000000000001817.
Exocrine pancreatic insufficiency is a frequent and clinically relevant complication of pancreatic cancer probably secondary to pancreatic duct obstruction. We aimed at evaluating the impact of endoscopic pancreatic drainage on pancreatic function in patients with unresectable pancreatic cancer.
A double-blind, prospective, randomized, single-center, interventional study was designed. Patients undergoing endoscopic retrograde cholangiopancreatography for jaundice secondary to unresectable pancreatic cancer were randomized to biliary drainage (group A) or biliopancreatic drainage (group B). Pancreatic function was evaluated by 13C-mixed triglyceride breath test before and 2 weeks after endoscopic retrograde cholangiopancreatography. Breath test result is expressed as 13C-cumulative recovery rate. Abdominal symptoms and nutritional markers were evaluated as secondary outcomes.
Twenty patients were included. Sixteen patients had exocrine pancreatic insufficiency, and 13 completed the study (7 in group A and 6 in group B). The median absolute improvement of 13C-cumulative recovery rate was of 23.75% (interquartile range, 9.62-31.74) after biliopancreatic drainage compared with -1.92% (interquartile range, -4.17 to 13.92) after biliary drainage (P = 0.015). Nutritional markers improved after biliopancreatic drainage, but not after biliary drainage.
Biliopancreatic and not biliary endoscopic drainage is associated with a significant improvement of exocrine pancreatic function in patients with unresectable pancreatic cancer.
外分泌胰腺功能不全是胰腺癌的一种常见且具有临床意义的并发症,可能继发于胰管阻塞。我们旨在评估内镜胰腺引流术对不可切除胰腺癌患者胰腺功能的影响。
设计了一项双盲、前瞻性、随机、单中心、干预性研究。因不可切除的胰腺癌所致的黄疸而行内镜逆行胰胆管造影术的患者被随机分为胆道引流组(A 组)或胰胆管引流组(B 组)。在接受内镜逆行胰胆管造影术之前和之后 2 周,通过 13C-混合三酸甘油酯呼吸试验评估胰腺功能。呼吸试验结果以 13C-累积回收率表示。将腹部症状和营养标志物作为次要结局进行评估。
共纳入 20 例患者。16 例患者存在外分泌胰腺功能不全,其中 13 例完成了研究(A 组 7 例,B 组 6 例)。与胆道引流相比,胰胆管引流后 13C-累积回收率的绝对改善中位数为 23.75%(四分位距,9.62-31.74),而胆道引流后为-1.92%(四分位距,-4.17 至 13.92)(P = 0.015)。胰胆管引流后营养标志物改善,但胆道引流后无改善。
与胆道引流相比,不可切除的胰腺癌患者行胰胆管引流与外分泌胰腺功能的显著改善相关。